Company Update

Oxygenta Pharmaceutical has confirmed its compliance regarding dematerialized securities for the quarter ended June 30, 2025. The company certified that all details concerning shares converted to electronic form during this period were furnished to stock exchanges.

Its Registrar and Share Transfer Agent verified that securities received for dematerialization were processed efficiently, with records updated for NSDL and CDSL within 15 days.

This signifies the company's adherence to proper share transfer procedures and investor record-keeping.